ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE
CENTER
FOR DRUG EVALUATION AND RESEARCH
Executive Secretary
Advisors and
Consultants Staff HFD-21
Center for Drug
Evaluation and Research
Food and Drug
Administration
Rockville, Maryland 20857
301/827-7001 FAX 301/827-6776
spelllesaned@cder.fda.gov
Thomas O. Carpenter, M.D.
Expertise: Pediatric
Endocrinology
Term: 7/1/03-6/30/07
Professor of
Endocrinology Pediatrics
Assistant
Institute Director for Biostatistics
National
Institutes of Allergy
and
Infectious Diseases
6700B
5050
*Steven W. Ryder, M.D.
Expertise:
Endocrinology
Term: 2/2/04-10/31/07
Senior Vice President
Pfizer Global
Research & Development
*Industry
Representative
David S. Schade, M.D.
Expertise: Endocrinology/Metabolism
Term: 2/13/03-06/30/06
Professor of Medicine and Chief,
Division of Endocrinology
University of
2211 Lomas Blvd NE 5-ACC
Albuquerque, New Mexico 87131
Morris Schambelan, M.D.
Expertise:
Endocrinology
Term: 7/1/03-6/30/07
Chief, Division of
Endocrinology
Building 30, Room
350K
Internal Medicine
Professor, Clinical
Endocrinology
Director, UC Bone Health
Cincinnati, Ohio 45219
Margaret E. Wierman, M.D.
Expertise:
Endocrinology
Chief, Section of
Endocrinology
ENDOCRINOLOGIC
AND METABOLIC DRUGS ADVISORY COMMITTEE
CENTER
FOR DRUG EVALUATION AND RESEARCH
Cont.
Chairman, Department
of Medicine
Coordinator,
Wisconsin Domestic Violence Training Project
Department of Women’s
Studies
and Continuing
Studies
University of
313
**Consumer
Representative
Updated